Shareholders to Vote on Major Capital Reorganization to Offset Accumulated Losses

summarizeSummary

Haoxi Health Technology is seeking shareholder approval to reduce the par value of its shares and reorganize its authorized capital, a move intended to create a distributable reserve to offset accumulated losses and clean up its balance sheet.

check_boxKey Events

• Share Capital Reorganization Proposed

  Shareholders are called to an Extraordinary General Meeting on July 6, 2026, to vote on a proposal to reduce and reorganize the company's authorized share capital.

• Par Value Reduction

  The proposal includes reducing the par value of both issued and unissued Class A and Class B ordinary shares from US$0.32 to US$0.0000001 each.

• Balance Sheet Clean-Up

  This capital reduction aims to create a distributable reserve account, which can be utilized to eliminate accumulated losses, addressing a significant financial hurdle for the company.

• Authorized Capital Value Decreases

  The total authorized share capital value will decrease from US$35.2 trillion to US$11 million, while the number of authorized shares (100 trillion Class A and 10 trillion Class B) remains unchanged.

auto_awesomeAnalysis

This filing details a critical step in Haoxi Health Technology's financial restructuring, following recent approvals for a massive increase in authorized shares. The proposed reduction in par value and reorganization of authorized share capital is designed to create a distributable reserve. This reserve can then be used to offset the company's accumulated losses, a crucial balance sheet clean-up for a company that has reported massive net losses and a "going concern" warning. While not directly dilutive, this action is a necessary precursor for a distressed company to improve its financial appearance, potentially enabling future capital raises or other strategic transactions.